Safaroghli-Azar, Ava <br/><br/>
Anticancer effect of pan-PI3K inhibitor on multiple myeloma cells: Shedding new light on the mechanisms involved in BKM120 resistance.  [electronic resource] 

 -  European journal of pharmacology  Jan 2019 
 - 89-98 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1879-0712 
<br/><br/><label>Standard No.: </label>10.1016/j.ejphar.2018.10.036  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aminopyridines--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Caspase 3--metabolism<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Drug Resistance, Neoplasm--drug effects<br/>Enzyme Inhibitors--pharmacology<br/>G2 Phase Cell Cycle Checkpoints--drug effects<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Humans<br/>M Phase Cell Cycle Checkpoints--drug effects<br/>Morpholines--pharmacology<br/>Multiple Myeloma--pathology<br/>Phosphoinositide-3 Kinase Inhibitors<br/>Tumor Protein p73--metabolism